Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-21

Clinical Trial Update: Exploring Buckwheat's Glucose Lowering Potential

View source ↗

Summary

A completed clinical trial investigates whether buckwheat can lower blood glucose in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Boniface Hospital | Conditions: Type 2 Diabetes | Status: COMPLETED